Derma Sciences, Inc. Reports 2012 Fourth Quarter and Full Year Financial Results
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the fourth quarter and year ended December 31, 2012. Highlights of the fourth quarter of 2012 and recent weeks include:
•Net sales were $20.1 million in the fourth quarter of 2012, up 22% over the prior-year fourth quarter and up 2% sequentially; net sales for the year were $72.6 million, up 16% over 2011
•Net sales were $20.1 million in the fourth quarter of 2012, up 22% over the prior-year fourth quarter and up 2% sequentially; net sales for the year were $72.6 million, up 16% over 2011